Civil Class Action Complaint Courts Documents France Fraud Investment Listed Securities United States District Court for the Central District of California USAOctober 23, 2020

Alexandre Golovanov v. Innate Pharma SA et al: Class Action Complaint

Class Action Complaint alleging fraud in Alexandre Golovanov v. Innate Pharma S.A., described as being a French company that “purports to be a clinical-stage biotechnology company engaged in discovering and developing first-in-class therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients” and whose securities were listed on NASDAQ; Mondher Mahjoubi, and Laure-Helene Mercieret at the U. S. District Court for the Central District of California.


    • 17
    October 23, 2020
    Innate Pharma S.A., Mondher Mahjoubi, Laure-Helene Mercier
    Alexandre Golovanov
    Xx Xx Xx
    Investment, Listed Securities
    Fraud
    Laurence Rosen

    Topics

    France Fraud Investment Listed Securities USA

    Keywords

    Alexandre Golovanov AstraZeneca Innate Pharma S.A. Laure-Helene Mercier Mondher Mahjoubi